LexDanaLexDanabeta
Inventor

Simon Everitt

Inventor
Beaconsfield, GB

Overview

27→
Patents
2005–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds34%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes26%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
A61NElectrotherapy1%
PatentTitleYear
10,988,477GCN2 inhibitors and uses thereof202110,793,563GCN2 inhibitors and uses thereof20209,499,497'Compounds useful as inhibitors of indoleamine 2,3-dioxygenase'20169,096,602'Substituted pyrrolo[2,3-B]pyrazines as ATR kinase inhibitors'20159,073,875'Compounds useful as inhibitors of indoleamine 2,3-dioxygenase'20158,987,454'Azaindoles useful as inhibitors of JAK and other protein kinases'20158,962,642'5-cyano-4- (pyrrolo [2,3B] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors'20158,841,450'Compounds useful as inhibitors of ATR kinase'20148,722,889'Azaindoles useful as inhibitors of JAK and other protein kinases'20148,669,081'Compositions useful as inhibitors of protein kinases'20148,642,779'Compositions useful as inhibitors of protein kinases'20148,637,511'Aminopyrimidines useful as kinase inhibitors'20148,530,489'5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors'20138,501,446'Azaindoles useful as inhibitors of JAK and other protein kinases'20138,247,421'5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors'20128,188,281'Azaindoles useful as inhibitors of JAK and other protein kinases'20128,129,399'Aminopyrimidines useful as kinase inhibitors'20128,076,343'Benzimidazoles useful as inhibitors of protein kinases'20117,863,282'Compositions useful as inhibitors of protein kinases'20117,767,672'Aminopyrimidines useful as kinase inhibitors'20107,652,135'Compositions useful as inhibitors of protein kinases'20107,528,142'Aminopyrimidines useful as kinase inhibitors'20097,507,826'Azaindoles useful as inhibitors of JAK and other protein kinases'20097,179,826'Compositions useful as inhibitors of protein kinases'20077,091,343'Compositions useful as inhibitors of protein kinases'20066,989,385'Pyrazole compounds useful as protein kinase inhibitors'20066,846,928'Compositions useful as inhibitors of protein kinases'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005–2021Patents assigned to VERTEX PHARMA (27)· patent assignee history
2005–2016Based in Beaconsfield, GB· patent location history
2006–2012Based in Bucks, GB· patent location history
2009–2014Based in Beaconsfields, GB· patent location history
2010–2014Based in Oxfordshire, GB· patent location history
2011–2015Patents assigned to EVERITT SIMON (8)· patent assignee history
2011–2014Patents assigned to BINCH HAYLEY (7)· patent assignee history
2011–2014Patents assigned to MORTIMORE MICHAEL (7)· patent assignee history
2012–2015Patents assigned to CHARRIER JEAN-DAMIEN (6)· patent assignee history
2013–2021Based in Abingdon, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
VERTEX PHARMA272005–2021
EVERITT SIMONself82011–2015
BINCH HAYLEY72011–2014
MORTIMORE MICHAEL72011–2014
CHARRIER JEAN-DAMIEN62012–2015
Locations
LocationPatentsSpan
Beaconsfield, GB92005–2016
Abingdon, GB72013–2021
Bucks, GB52006–2012
Oxfordshire, GB32010–2014
Beaconsfields, GB32009–2014